U.S. Stem Cell, Inc. - 10-K/A filing on 2022-07-08

RELATED PARTY TRANSACTIONS (Details) - USD ($)																														12 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Nov. 09, 2021	Oct. 01, 2021	Apr. 01, 2021	Mar. 23, 2021	Feb. 10, 2021	Oct. 01, 2020	Apr. 01, 2020	Feb. 05, 2020	Oct. 01, 2019	Jul. 01, 2019	Oct. 19, 2018	May 07, 2018	Apr. 19, 2018	Oct. 02, 2017	Apr. 01, 2017	Mar. 09, 2017	Nov. 09, 2016	Oct. 06, 2016	Apr. 07, 2016	Oct. 07, 2015	Oct. 02, 2015	Apr. 03, 2015	Oct. 03, 2014	Apr. 02, 2014	Dec. 24, 2013	Sep. 30, 2013	Oct. 01, 2012	Sep. 21, 2012	Mar. 30, 2012	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2013	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 26, 2021	Sep. 30, 2020	Sep. 08, 2020	Jul. 01, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 15, 2019	Aug. 07, 2017	Dec. 31, 2015	Feb. 28, 2013	Feb. 29, 2012
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Due to Related Parties, Current																														$ 951,432	$ 861,432
Debt Instrument, Face Amount								$ 35,000																																			$ 500,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	226,713	743,341	187,575	7,518,797		2,035,820														34,522										28,891,144
Class of Warrant or Rights, Granted (in Shares)																															0
Percentage of Revenues to be Received as Royalty																	5.00%
Debt Instrument, Interest Rate, Stated Percentage								5.00%																																			5.25%
Preferred Stock, Shares Authorized (in Shares)																														20,000,000	20,000,000														20,000,000
Debt Conversion, Original Debt, Amount			$ 9,145																	$ 100,000										$ 375,586	$ 0
Debt Conversion, Converted Instrument, Amount		$ 8,921	10,879
Stock Issued During Period, Value, Other																														231,742	51,914
Paid-in-Kind Interest		9,195				$ 9,195																								19,800	21,744
Gain (Loss) on Extinguishment of Debt		$ 274	$ (1,734)		$ 100,000	(984)																								(151,410)	182
Stock Issued During Period, Value, Conversion of Convertible Securities						$ 10,179
Notes Payable, Related Parties																														3,144,200	2,721,478
Debt Instrument, Maturity Date								Feb. 05, 2021
Interest Payable																														166,424	208,645
Interest [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Conversion, Original Debt, Amount																														18,340	$ 18,340
Debt Conversion, Converted Instrument, Amount																														$ 586
Stock Issued During Period, Shares, Other (in Shares)																														930,916	3,481,467
Stock Issued During Period, Value, Other																														$ 19,800	$ 21,744
Gain (Loss) on Extinguishment of Debt																														1,459	3,404
Convertible Debt [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																				$ 200,000		$ 10,000
Debt Instrument, Interest Rate, Stated Percentage																																						5.00%
Interest Payable																														0	156
Series A Preferred Stock [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Preferred Stock, Voting Rights																											modify the voting rights of the subsequently cancelled Series A Convertible Preferred Stock from 20 votes per share on matters to be voted on by the common stockholders to 25 votes per share on matters to be voted on by the common stockholders and all prior and subsequent payments of interest will be in common stock
Stock Issued for Conversion of Series A Preferred Stock and Litigation Case [Member] \| Northstar Claims [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Other (in Shares)															1,000,000	30,000,000
Officers and Directors [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Proceeds from Related Party Debt																														90,000	349,688
Due to Related Parties, Current																														951,432	861,432
Affiliated Entity [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																															$ 544,267
Debt Conversion, Converted Instrument, Shares Issued (in Shares)							1,445,647		1,692,353		164,523		379,141	559,187	286,315										3,916	8,772
Debt Instrument, Payment Terms																											Company was obligated to issue additional preferred stock equal in lieu of payment of cash of accrued and unpaid interest on each six-month anniversary of the effective date (October 1, 2012).		agreed to extend until May 1, 2012 the initial payment date for any and all required monthly under the Note, such that the first of the four monthly payments required under the Note will be due and payable on May 1, 2012 and all subsequent payments will be due on a monthly basis thereafter commencing on June 1, 2012, and to waive any and all defaults and/or events of default under the Note with respect to such payments. The Company did not make the required payment, and as a result, was in default of the revised agreement. The Company renegotiated the terms of the Note and Northstar agreed to suspend the requirement of principal payments by the Company and allow payment of interest-only in common stock.
Class of Warrant or Rights, Granted (in Shares)																												5,000
Debt Instrument, Debt Default, Description of Violation or Event of Default																											entered into a limited waiver and forbearance agreement providing a recapitalized new note balance comprised of all sums due Northstar with a maturity date extended perpetually. The Company agreed to issue 5,000,000 shares of Series A Convertible Preferred Stock and 10,000 shares of common stock in exchange for $210,000 as payment towards outstanding debt, default interest, penalties, professional fees outstanding and due Northstar. In addition, the Company executed a security agreement granting Northstar a lien on all patents, patent applications, trademarks, service marks, copyrights and intellectual property rights of any nature, as well as the results of all clinical trials, know-how for preparing Myoblasts, old and new clinical data, existing approved trials, all right and title to Myoblasts, clinical trial protocols and other property rights.In addition, the Company granted Northstar a perpetual license on products as described for resale, relicensing, and commercialization outside the United States. In connection with the granted license, Northstar shall pay the Company a royalty of up to 8% on revenues generated.
Percentage of Revenues to be Received as Royalty																											8.00%
Debt Instrument, Interest Rate, Stated Percentage																											12.85%																			7.00%
Debt Conversion, Original Debt, Amount							$ 9,145						$ 9,145	$ 12,705	$ 12,703										$ 85,447	$ 100,000
Debt Conversion, Converted Instrument, Amount							11,565
Paid-in-Kind Interest									$ 9,195		$ 9,195
Gain (Loss) on Extinguishment of Debt							$ 2,420
Notes Payable, Related Parties																														262,000
Affiliated Entity [Member] \| Interest [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																		848,490	57,778		4,156	1,363	515	275
Debt Conversion, Original Debt, Amount																		$ 12,705			$ 12,705	$ 12,635	$ 12,705	$ 12,635
Debt Conversion, Converted Instrument, Amount																			$ 12,705
Affiliated Entity [Member] \| Series A Preferred Stock [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Value, Other																																$ 316,800
Chief Executive Officer [Member] \| Note Payable #5 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																												$ 500,000
Debt Instrument, Interest Rate, Stated Percentage																																												5.00%
Notes Payable, Related Parties																														161,786	161,786
Chief Executive Officer [Member] \| Note Payable #6 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount												$ 500,000
Debt Instrument, Interest Rate, Stated Percentage												5.00%
Notes Payable, Related Parties																														500,000	500,000
Debt Instrument, Term												6 months
Chief Executive Officer [Member] \| Note Payable #7 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount										$ 500,000
Debt Instrument, Interest Rate, Stated Percentage										5.00%
Notes Payable, Related Parties																														500,000	500,000
Chief Executive Officer [Member] \| Note Payable #8 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																																										5.00%
Notes Payable, Related Parties																														178,077	178,077
Chief Executive Officer [Member] \| Note Payable #9 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																									$ 187,500
Debt Instrument, Interest Rate, Stated Percentage																																									5.00%
Notes Payable, Related Parties																														187,500	187,500
Chief Executive Officer [Member] \| Note Payable #10 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																								$ 187,500
Debt Instrument, Interest Rate, Stated Percentage																																								5.00%
Notes Payable, Related Parties																														187,500	187,500
Chief Executive Officer [Member] \| Note Payable #11 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																							$ 500,000
Debt Instrument, Interest Rate, Stated Percentage																																							5.00%
Notes Payable, Related Parties																														500,000	500,000
Chief Executive Officer [Member] \| Note Payable #12 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																					$ 100,962
Debt Instrument, Interest Rate, Stated Percentage																																					5.00%
Notes Payable, Related Parties																														100,962	100,962
Chief Executive Officer [Member] \| Note Payable #13 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																															$ 143,654
Debt Instrument, Interest Rate, Stated Percentage																															5.00%
Notes Payable, Related Parties																														143,654	$ 143,653
Chief Executive Officer [Member] \| Note Payable #14 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																			$ 90,990
Debt Instrument, Interest Rate, Stated Percentage																																			5.00%
Notes Payable, Related Parties																														90,990	0
Chief Executive Officer [Member] \| Note Payable #15 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																		$ 43,269
Debt Instrument, Interest Rate, Stated Percentage																																		5.00%
Notes Payable, Related Parties																														43,269	0
Chief Executive Officer [Member] \| Note Payable #16 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																																	$ 187,500
Debt Instrument, Interest Rate, Stated Percentage																																	5.00%
Notes Payable, Related Parties																														187,500	0
Chief Executive Officer [Member] \| Note Payable #17 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Face Amount																														$ 100,962
Debt Instrument, Interest Rate, Stated Percentage																														5.00%
Notes Payable, Related Parties																														$ 100,962	0
Chief Scientific Officer [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Interest Payable																														$ 612,323	$ 482,468
Chief Scientific Officer [Member] \| Note Payable #5 [Member] \| Notes Payable, Other Payables [Member]
RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Maturity Date										Nov. 07, 2019